Venture NAV Tracker / Fund
Horizon Technology Finance Corporation (HRZN)
An externally managed BDC providing secured venture loans to technology and life science companies; its merger with Monroe Capital Corporation closed 2026-04-14, after the Q1 balance-sheet date.
Structureventure debt BDC
ExchangeNASDAQ
NAV / share$6.98Mar 31, 2026 · source ↗
Market price$4.66Jul 17, 2026 · source ↗
Premium / discount-33.2%Derived from latest NAV and price
Net assets$333.9MMar 31, 2026 · source ↗
Latest observation
NAV vs. market price
Reported dates shown below.
Schedule of investments
Debt investments
Mar 31, 2026 reporting period
| Company | Security type | Principal | Cost | Fair value | FV / principal | Rate | Maturity | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| Pelthos TherapeuticsBiotechnology | senior secured loan | $30MMar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | $29.4MMar 31, 2026 · source ↗ | 97.9%Mar 31, 2026 · source ↗ | P+3.75% (10.50% floor, 5.00% ETP)Mar 31, 2026 · source ↗ | Jan 31, 2031Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
| Castle Creek BiosciencesBiotechnology | senior secured loan | $25.5MMar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | $25.4MMar 31, 2026 · source ↗ | 99.5%Mar 31, 2026 · source ↗ | P+4.25% (12.00% floor, 4.00% ETP)Mar 31, 2026 · source ↗ | Mar 1, 2028Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
| Long Grove PharmaceuticalsPharmaceuticals | senior secured loan | $10.4MMar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | $10.2MMar 31, 2026 · source ↗ | 98.0%Mar 31, 2026 · source ↗ | 1M SOFR+4.00% (6.00% floor)Mar 31, 2026 · source ↗ | Feb 27, 2031Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Schedule of investments
Warrant & equity positions
Mar 31, 2026 reporting period
| Company | Fair value | % of NAV | Security | Implied price / share | Methodology / source |
|---|
Position history
Reported fair-value marks
Each bar is a disclosed position-quarter.